US pharmaceutical giant Johnson & Johnson on Friday announced plans to break up into two entities, turning its consumer health arm into a separate company. Johnson & Johnson said in a statement it will separate...
Lotus Herbals picks up 32% stake in dermaceuticals maker Fixderma India
Beauty and personal care products company Lotus Herbals on Wednesday said it has bought a 32% stake in dermaceuticals maker Fixderma India. The investment will give Lotus Herbals entry into the dermaceuticals segment in...
CCI clears Phoenix Parentco’s acquisition of Parexel International Corporation
Competition Commission of India (CCI) on Monday approved the acquisition of Parexel International Corporation by Phoenix Parentco Inc. Headquartered in the US, Paraxel provides biopharmaceutical outsourcing services to...
Piramal board okays demerger of pharma, financial services operations
Piramal Enterprises Ltd said on Thursday that its board has approved the restructuring of the company’s business to demerge its financial services and pharmaceuticals operations into two separate listed entities...
Temasek buys into True North-backed pharma firm Integrace
Temasek Holdings will invest Rs 540 crore through a mix of primary and secondary for a stake in Integrace, a therapy-focused healthcare company. Home-grown private equity firm True North, which owns Integrace, has...
Pfizer to sell Upjohn business to Mylan Pharma for ₹180.48 crore
Drug firm Pfizer Ltd on Friday said it has entered into an agreement with Mylan Pharmaceuticals to sell its Upjohn business for ₹180.48 crore. The company has entered into a business transfer agreement with Mylan...
Merck to buy Acceleron Pharma for $11.5 billion
Merck & Co. has agreed to buy Acceleron Pharma Inc. for $11.5 billion, bolstering the pharmaceutical giant’s rare-disease business. The cash deal values Acceleron at $180 a share, the companies said Thursday. The...
After acquisition of DHFL, Piramal Group sets eyes on demerger of pharma business
Billionaire Ajay Piramal sealed the takeover of stressed Dewan Housing Finance Corporation (DHFL) after a year-long battle with global funds that would position the family to realise its decade-old dream of making it...
Merck in advanced talks to buy Acceleron Pharma – WSJ
Merck & Co is in advanced talks to acquire drugmaker Acceleron Pharma Inc, the Wall Street Journal reported on Monday, citing people familiar with the matter. A potential deal could help Merck, which sells the...
Australia’s API gets $561 million offer from Sigma Healthcare, rivals Wesfarmers bid
Australian Pharmaceutical Industries on Monday received a non-binding proposal from Sigma Healthcare valuing it at A$773.5 million ($561.4 million), rivalling an offer from retail conglomerate Wesfarmers. API earlier in...
Drugmaker SOBI soars on $8 billion bid from Advent and Singapore’s GIC
Swedish drugmaker Orphan Biovitrum (SOBI) has agreed an $8 billion takeover by U.S. private equity firm Advent International and Singapore’s sovereign wealth fund, boosting its shares on speculation of a higher offer...
Everstone snaps up Calibre Chemicals for about $100 million
Singapore-headquartered private equity major Everstone Capital on Tuesday announced acquisition of a controlling stake in Calibre Chemicals, which is a specialty ingredients player focused on the pharmaceutical...
